Thiazol-2-yl-imine compounds as PDE-7 inhibitors
    1.
    发明公开
    Thiazol-2-yl-imine compounds as PDE-7 inhibitors 审中-公开
    噻唑-5-基 - 亚胺基PDE7-抑制素

    公开(公告)号:EP1348433A1

    公开(公告)日:2003-10-01

    申请号:EP02290787.7

    申请日:2002-03-28

    CPC分类号: C07D417/04 C07D277/42

    摘要: A compound selected from those of formula (I):
    wherein:

    R 1 represents cycloalkyl, heterocycloalkyl, aryl or heteroaryl group, which are optionally substituted as defined in the description,
    R 2 represents alkyl, alkenyl, alkynyl, aryl or cycloalkyl group,
    R 3 represents cycloalkyl, heterocycloalkyl, aryl or heteroaryl group, which are optionally substituted by halogen, nitro, cyano, trifluoromethyl, oxo, alkyl, OR 6 , NR 6 R 7 , COR 6 , CO 2 R 6 , CONHOH, CONR 6 R 7 , -S(O) m R 6 , -S(O) m -NR 6 R 7 , -NR 6 COR 7 , -NR 6 SO 2 R 7 , -N(SO 2 R 7 ) 2 , -NR 6 -CO-NR 7 R 8 , and tetrazolyl, wherein m, R 6 , R 7 and R 8 , are as defined in the description,
    and optionally, its optical isomers , N-oxide, and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are useful as specific inhibitors of phosphosdiesterase-7 (PDE7).

    摘要翻译: 选自式(I)的化合物:其中:R 1表示环烷基,杂环烷基,芳基或杂芳基,其如说明书中所定义,任选被取代,R 2表示烷基,烯基,炔基,芳基或环烷基, 硝基,氰基,三氟甲基,氧代,烷基,OR 6,NR 6 R 7,COR 6,CO 2 R 6,CONHOH,CONR 6 R 7,-S(O)m R 6,-S( O)m -NR 6 R 7,-NR 6 COR 7,-NR 6 SO 2 R 7,-N(SO 2 R 7)2,-NR 6 -CO-NR 7 R 8和四唑基,其中m,R 6,R 7和R 8如说明书中所定义, 异构体,N-氧化物及其与药学上可接受的酸或碱的加成盐,以及含有它们的药物可用作磷酸二酯酶-7(PDE7)的特异性抑制剂。

    (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
    4.
    发明公开
    (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors 审中-公开
    2,4-二取代噻唑-5-基 - 胺的PDE7-抑制剂

    公开(公告)号:EP1348701A1

    公开(公告)日:2003-10-01

    申请号:EP02290788.5

    申请日:2002-03-28

    CPC分类号: C07D417/04 C07D277/42

    摘要: A compound selected from those of formula (I):
    wherein:

    R 1a represents hydrogen, alkyl, or arylalkyl group,
    R 1b represents cycloalkyl, heterocycloalkyl, aryl or heteroaryl group, which are optionally substituted as defined in the description,
    R 2 represents alkyl, alkenyl, alkynyl, aryl or cycloalkyl group,
    R 3 represents cycloalkyl, heterocycloalkyl, aryl or heteroaryl group, which are optionally substituted by halogen, nitro, cyano, trifluoromethyl, oxo, alkyl, OR 6 , NR 6 R 7 , COR 6 , CO 2 R 6 , CONHOH, CONR 6 R 7 , -S(O) m R 6 , -S(O) m -NR 6 R 7 , -NR 6 COR 7 , -NR 6 SO 2 R 7 , -N(SO 2 R 7 ) 2 , -NR 6 -CO-NR 7 R 8 , and tetrazolyl, wherein m, R 6 , R 7 and R_, are as defined in the description,
    and optionally, its optical isomers , N-oxide, and addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal products containing the same are useful as specific inhibitors of phosphosdiesterase-7 (PDE-7).

    摘要翻译: 选自式(I)的化合物:其中:R 1a表示氢,烷基或芳基烷基,R 1b表示环烷基,杂环烷基,芳基或杂芳基,其如说明书中所定义任选被取代,R 2表示烷基 硝基,氰基,三氟甲基,氧代,烷基,OR 6,NR 6 R 7,COR 6,CO 2 R 6,CONHOH,CONR 6 R 7, -S(O)m R 6,-S(O)m -NR 6 R 7,-NR 6 COR 7,-NR 6 SO 2 R 7,-N(SO 2 R 7)2,-NR 6 -CO-NR 7 R 8和四唑基,其中m,R 6,R 7和R 8为 并且任选地,其光学异构体,N-氧化物及其与药学上可接受的酸或碱的加成盐,以及含有它们的药物可用作磷酸二酯酶-7(PDE-7)的特异性抑制剂。